MAPT and Alzheimer disease: In symptomatic AD, tau pathology is a more direct predictor of cognitive progression than Aβ (Jagust, 2013; Koch et al., 2014); together with parietal white matter lesions, tau has been shown to contribute to early development of AD (Maruyama et al., 2004; Hertze et al., 2013).